Revvity Inc. $RVTY Stake Cut by Gotham Asset Management LLC

Key Points

• Gotham Asset Management LLC reduced its stake in Revvity Inc. by 33.8%, selling 55,403 shares and now owning 108,353 shares valued at approximately $11.46 million.
• Revvity reported earnings per share of $1.18 for the latest quarter, surpassing analyst estimates, and noted a 4.1% year-over-year revenue increase to $720.28 million.
• The company has declared a quarterly dividend of $0.07, with a payout ratio of 11.86%, indicating a commitment to returning value to shareholders.

Gotham Asset Management LLC cut its position in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 33.8% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 108,353 shares of the company's stock after selling 55,403 shares during the quarter. Gotham Asset Management LLC owned 0.09% of Revvity worth $11,464,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Vermillion Wealth Management Inc. bought a new position in Revvity during the fourth quarter worth $41,000. New Age Alpha Advisors LLC bought a new stake in Revvity in the first quarter valued at $44,000. Continuum Advisory LLC lifted its stake in Revvity by 39.3% in the fourth quarter. Continuum Advisory LLC now owns 471 shares of the company's stock valued at $53,000 after buying an additional 133 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in Revvity by 25.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company's stock valued at $73,000 after buying an additional 140 shares during the last quarter. Finally, Cary Street Partners Investment Advisory LLC bought a new stake in Revvity in the first quarter valued at $75,000. 86.65% of the stock is currently owned by institutional investors.

Revvity Price Performance

Shares of NYSE RVTY opened at $86.50 on Friday. Revvity Inc. has a fifty-two week low of $81.36 and a fifty-two week high of $129.50. The firm's 50-day simple moving average is $93.06 and its 200 day simple moving average is $97.11. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43. The stock has a market cap of $10.04 billion, a P/E ratio of 36.65, a P/E/G ratio of 2.33 and a beta of 0.94.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, July 28th. The company reported $1.18 earnings per share for the quarter, beating analysts' consensus estimates of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The business had revenue of $720.28 million for the quarter, compared to analysts' expectations of $711.26 million. During the same period in the previous year, the business earned $1.22 earnings per share. The company's revenue was up 4.1% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. Equities analysts expect that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be given a $0.07 dividend. The ex-dividend date is Friday, October 17th. This represents a $0.28 annualized dividend and a yield of 0.3%. Revvity's payout ratio is 11.86%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. Stifel Nicolaus cut their target price on Revvity from $120.00 to $110.00 and set a "hold" rating on the stock in a research note on Tuesday, July 29th. Raymond James Financial reiterated an "outperform" rating and issued a $115.00 target price (down from $120.00) on shares of Revvity in a research note on Tuesday, July 29th. Evercore ISI cut their target price on Revvity from $116.00 to $115.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 8th. Wall Street Zen cut Revvity from a "buy" rating to a "hold" rating in a research note on Sunday, August 3rd. Finally, Bank of America cut their target price on Revvity from $116.00 to $110.00 and set a "buy" rating on the stock in a research note on Thursday, June 26th. Ten research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $120.07.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.